Prof. Dr. Joost de Bruijn*

Qualifications: BSc, PhD

Joined Kuros in 2017

Joost de Bruijn, PhD, FBSE, is President, Innovation and Strategy & Executive Director of Kuros. He held the position of Chief Executive Officer of Kuros Biosciences AG (SIX: KURN) from 2017 to 2023. He also holds the position of Professor of Biomaterials at Queen Mary University of London, UK (since 2004) and was Professor of Regenerative Medicine and Entrepreneurship at Twente University, The Netherlands from 2011-2019. Prof. Dr. de Bruijn was the founder and CEO of Xpand Biotechnology B.V. that was acquired by Kuros Biosciences AG early 2017. Prior to this, he was involved with Progentix Orthobiology BV (founder & CEO) that was acquired by NuVasive Inc. (now Globus Medical, Inc.), Scinus Cell Expansion BV (founder & CEO) and IsoTis Orthobiologics NV.

Prof. Dr. de Bruijn has 35 years of experience in academia and the life science industry and, as a serial entrepreneur, has brought several technologies to the clinic. He is author on close to 200 peer-reviewed publications and an inventor of 35 patents and patent families. Prof. Dr. de Bruijn is scientific editor of the world’s first open-access journal, European Cells and Materials, and reviewer for numerous international biomaterials, tissue engineering and regenerative medicine journals. He received his PhD Cum Laude from Leiden University in 1993 and is a citizen of The Netherlands.

*Joost de Bruijn is a member of the Executive Committee and the Board of Directors.